Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 99700
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99700
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99700
Risk of lupus to pregnancy | Risk of pregnancy to lupus |
Pregnancy loss | Lupus flares |
Pre-term delivery | Progressive renal disease |
Eclampsia | Maternal thromboembolism |
Neonatal lupus due to Ro and La antibodies |
Before pregnancy | Every 6-8 weeks (adjustable)1 |
Complete metabolic panel | Complete metabolic panel |
Prothrombin time/partial thromboplastin time | |
24-h urinary protein and creatinine clearance2 | |
sPCR | sPCR |
Anti-dsDNA | Anti-dsDNA |
Anti-Ro/SS-A and anti-La/SS-B antibodies | |
Lupus anticoagulant3 | |
Anticardiolipin IgG, IgM, IgA3 | |
Anti-β2 glycoprotein I IgG, IgM, IgA3 | |
Complement levels (C3, C4) | Complement levels (C3, C4) |
Uric acid | Uric acid |
Urine detailed report with microscopy | Urine detailed report with microscopy |
Medications | Before conception | During pregnancy | Lactation |
Stop at conception | |||
Abatacept | Stop with the positive pregnancy test | + | |
Belimumab | Stop with the positive pregnancy test | + | |
Rituximab | Stop with the positive pregnancy test | + | |
Compatible drugs | |||
Hydroxychloroquine | + | + | + |
Azathioprine | + | + | + |
Cyclosporine | + | + | + |
Tacrolimus | + | + | + |
Sulfasalazine | + | + | + |
Prednisone | Dose < 20 mg/day | Dose < 20 mg/day | Dose < 20 mg/day |
NSAIDs | Discontinue w/difficulty conceiving | Stop at week 20 | + |
Non-compatible drugs | |||
Cyclophosphamide | Stop 3 months before conception | x | x |
MMF/mycophenolic acid | Stop 6 weeks before conception | x | x |
Methotrexate | Stop 1-3 months before conception | x | x low transfer into breast milk |
Features | Lupus nephritis | Pre-eclampsia |
Timing | Any time during pregnancy | After 20 weeks of gestation |
Hypertension | Can be present or absent | Always present |
Other organ involvement | Present (e.g., skin, joints) | Absent |
Complement levels (C3, C4) | Decreased or normal | Normal |
Anti-dsDNA | Positive | Negative |
Lupus serology | Active disease markers present | Usually absent |
Active urinary sediment Urinary calcium Response to steroids | Present | Absent |
> 195 mg/d | < 195 mg/d | |
Generally responsive | No response | |
Platelet count | Usually normal or mildly low | Often low (thrombocytopenia) |
Liver enzymes | Usually normal | Elevated (HELLP syndrome) |
- Citation: Elahi T, Ahmed S, Mubarak M. Relationship of lupus nephritis and pregnancy: A narrative review. World J Nephrol 2024; 13(4): 99700
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/99700.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.99700